Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment.

doi:10.1016/S1473-3099(13)70006-9

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment.

The Lancet. Infectious diseases - 1 May 2013

Vogel Ulrich, Taha Muhamed-Kheir, Vazquez Julio A, Findlow Jamie, Claus Heike, Stefanelli Paola, Caugant Dominique A, Kriz Paula, Abad Raquel, Bambini Stefania, Carannante Anna, Deghmane Ala Eddine, Fazio Cecilia, Frosch Matthias, Frosi Giacomo, Gilchrist Stefanie, Giuliani Marzia M, Hong Eva, Ledroit Morgan, Lovaglio Pietro G, Lucidarme Jay, Musilek Martin, Muzzi Alessandro, Oksnes Jan, Rigat Fabio, Orlandi Luca, Stella Maria, Thompson Danielle, Pizza Mariagrazia, Rappuoli Rino, Serruto Davide, Comanducci Maurizio, Boccadifuoco Giuseppe, Donnelly John J, Medini Duccio, Borrow Ray

Abstract excerpt

BACKGROUND: A novel multicomponent vaccine against meningococcal capsular group B (MenB) disease contains four major components: factor-H-binding protein, neisserial heparin binding antigen, neisserial adhesin A, and outer-membrane vesicles derived from the strain NZ98/254. Because the public health effect of the vaccine, 4CMenB (Novartis Vaccines and Diagnostics, Siena, Italy), is unclear, we assessed the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adhesins, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antigens, Bacterial

Share to Enzyme-Linked Immunosorbent Assay

Share to Meningitis, Meningococcal

Share to Meningococcal Vaccines

Share to Multilocus Sequence Typing

Share to Neisseria meningitidis, Serogroup B

Share to Population Surveillance

Source

Open in PubMed

Identifiers

PMID: 23414709
DOI: 10.1016/S1473-3099(13)70006-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment.PMID 23414709Read ↗

Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences with Other European CountriesSemantic proximity Read ↗

Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine.Semantic proximity Read ↗

Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 Neisseria meningitidis isolates causing invasive meningococcal disease in Argentina in 2010-2014.Semantic proximity Read ↗

Predicted coverage by 4CMenB vaccine against invasive meningococcal disease cases in the NetherlandsSemantic proximity Read ↗

Genomic Characterization of Invasive Meningococcal Serogroup B Isolates and Estimation of 4CMenB Vaccine Coverage in Finland.Semantic proximity Read ↗

MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccineSemantic proximity Read ↗

The Development of a Vaccine Against Meningococcus B Using Reverse VaccinologySemantic proximity Read ↗

Bioinformatics Analysis of Global Diversity in Meningococcal Vaccine Antigens over the Past 10 Years; Vaccine Efficiency PrognosisSemantic proximity Read ↗

Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effectSemantic proximity Read ↗

Genomic characterization of invasive Neisseria meningitidis in Spain (2011/12–2022/23): expansion of clonal complex 213 and the potential threat to 4CMenB vaccine strain coverageSemantic proximity Read ↗

Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in England, Wales, and Northern Ireland, 2007–08 and 2014–15: a qualitative and quantitative assessmentSemantic proximity Read ↗

Prediction by genetic MATS of 4CMenB vaccine strain coverage of invasive meningococcal serogroup B isolates circulating in Taiwan between 2003 and 2020.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.